Update: 22.11.2022
Last week: 45 week 2022 (07.11.2022 - 13.11.2022)
Last full month: October 2022
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 123 524 | -3.6% | 3.2% | -0.3 | 28 293 190 | -1.3% | 3.3% | -0.3 | 4.4% |
| MoM | 663 634 | -11.2% | 3.7% | 0 | 141 897 078 | -7.6% | 3.9% | 0.1 | -11.7% |
| YTD | 8 571 690 | -22.9% | 5.2% | -1.2 | 1 717 188 600 | -9.5% | 5.0% | -0.8 | -4.5% |
| MAT | 10 725 582 | -11.0% | 5.3% | -0.4 | 2 111 038 054 | 2.7% | 5.1% | -0.1 | -5.0% |
| DEXALGIN | |||||||||
| WoW | 15 879 | 5.6% | 0.4% | 0 | 7 950 277 | 7.8% | 1.2% | 0 | 3.0% |
| MoM | 86 956 | -4.2% | 0.4% | 0 | 43 128 669 | -0.4% | 1.4% | 0.2 | -15.1% |
| YTD | 1 456 557 | -3.7% | 0.7% | 0 | 623 298 532 | 8.4% | 1.8% | 0 | -0.8% |
| MAT | 1 782 204 | 0.7% | 0.7% | 0 | 749 385 536 | 11.9% | 1.9% | 0.1 | -2.4% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 56 930 | 13.0% | 40.6% | -1.8 | 30 696 566 | 14.9% | 47.3% | -2 | 18.1% |
| MoM | 239 485 | -14.9% | 42.7% | -3.6 | 125 979 753 | -15.3% | 49.0% | -3 | -7.8% |
| YTD | 3 894 911 | -14.1% | 54.7% | -11.8 | 1 985 622 814 | -3.9% | 60.2% | -10.4 | 4.5% |
| MAT | 4 642 600 | -11.4% | 55.8% | -10.3 | 2 343 224 365 | -0.9% | 61.4% | -8.9 | 4.9% |
| ESPUMISAN BABY | |||||||||
| WoW | 23 604 | 10.7% | 34.1% | 2.1 | 15 821 626 | 14.4% | 47.4% | 2.1 | 3.7% |
| MoM | 100 666 | -10.7% | 32.4% | -2.5 | 65 668 391 | -11.0% | 45.8% | -2.4 | -3.7% |
| YTD | 1 260 762 | -13.3% | 37.6% | -4.1 | 789 779 613 | -6.9% | 50.8% | -5.7 | -3.9% |
| MAT | 1 469 108 | -15.0% | 37.8% | -4 | 913 253 789 | -8.3% | 51.2% | -5.1 | -6.1% |
| FASTUM | |||||||||
| WoW | 16 940 | 12.9% | 1.0% | 0 | 9 627 629 | 13.6% | 2.4% | 0.1 | 7.6% |
| MoM | 64 329 | -16.9% | 0.8% | -0.1 | 36 346 604 | -13.8% | 2.1% | -0.1 | -7.5% |
| YTD | 928 955 | -23.8% | 1.1% | -0.3 | 482 808 123 | -13.9% | 2.5% | -0.6 | -0.3% |
| MAT | 1 094 292 | -23.9% | 1.1% | -0.3 | 562 107 889 | -14.4% | 2.6% | -0.6 | -1.7% |
| IODOMARIN | |||||||||
| WoW | 70 622 | 6.2% | 23.2% | -0.2 | 13 159 934 | 6.5% | 9.8% | -0.2 | 7.2% |
| MoM | 358 258 | 6.7% | 24.2% | -0.2 | 66 228 362 | 6.5% | 10.6% | -0.2 | 7.5% |
| YTD | 2 821 112 | 5.2% | 20.3% | 0 | 553 082 687 | 9.9% | 9.1% | -0.1 | 5.1% |
| MAT | 3 305 225 | 13.1% | 20.6% | 1.6 | 642 213 144 | 16.0% | 9.3% | 0.5 | 4.6% |
| LIOTON | |||||||||
| WoW | 17 092 | 25.5% | 1.8% | 0.3 | 19 297 838 | 27.3% | 4.3% | 0.8 | 2.0% |
| MoM | 68 286 | -18.3% | 1.6% | -0.2 | 75 928 498 | -15.9% | 3.8% | -0.1 | -7.2% |
| YTD | 1 138 741 | -24.7% | 2.3% | -0.5 | 1 174 068 091 | -5.6% | 4.6% | -1 | -7.4% |
| MAT | 1 318 790 | -23.1% | 2.3% | -0.5 | 1 333 021 725 | -4.7% | 4.7% | -0.8 | -8.1% |
| MEZYM | |||||||||
| WoW | 210 162 | 8.0% | 18.5% | 0.4 | 31 237 965 | 8.0% | 13.0% | 0.3 | 5.8% |
| MoM | 920 938 | -9.0% | 18.8% | -0.1 | 140 372 345 | -9.1% | 13.5% | 0.2 | -8.4% |
| YTD | 15 713 445 | -10.6% | 26.4% | -2.4 | 2 401 512 979 | -2.2% | 18.9% | -2.6 | -2.6% |
| MAT | 18 900 840 | -7.7% | 27.1% | -1.5 | 2 855 464 945 | -0.0% | 19.5% | -1.9 | -2.6% |
| MIG 400 | |||||||||
| WoW | 130 056 | 4.8% | 2.9% | 0 | 15 717 210 | 4.7% | 2.3% | 0 | 3.0% |
| MoM | 590 420 | -16.3% | 2.8% | 0 | 71 281 785 | -15.1% | 2.2% | 0 | -15.1% |
| YTD | 7 414 619 | -14.3% | 3.3% | -0.5 | 874 457 719 | -10.3% | 2.5% | -0.6 | -0.8% |
| MAT | 8 651 871 | -12.7% | 3.3% | -0.4 | 1 016 648 412 | -8.9% | 2.6% | -0.5 | -2.4% |
| PROSTAMOL | |||||||||
| WoW | 23 828 | 15.4% | 14.1% | 0 | 33 164 846 | 17.8% | 15.2% | 0.4 | 15.1% |
| MoM | 104 788 | -2.2% | 15.4% | 0.3 | 144 315 206 | -3.2% | 16.3% | 0.2 | -4.2% |
| YTD | 1 380 565 | -26.3% | 18.9% | -6.1 | 1 933 169 181 | -17.8% | 20.1% | -7.1 | -2.4% |
| MAT | 1 647 403 | -24.1% | 19.3% | -5.2 | 2 282 385 923 | -15.9% | 20.6% | -6 | -3.8% |
| RESPERO MYRTOL | |||||||||
| WoW | 21 709 | 12.5% | 7.0% | 0.4 | 10 965 619 | 16.5% | 7.6% | 0.6 | 6.8% |
| MoM | 99 923 | -10.4% | 7.6% | -0.1 | 48 921 001 | -8.4% | 7.9% | -0.1 | -9.0% |
| YTD | 1 069 028 | 93.9% | 8.6% | 4.2 | 503 238 026 | 94.8% | 8.6% | 3.7 | 0.4% |
| MAT | 1 264 640 | 98.1% | 8.6% | 4.2 | 589 772 588 | 96.5% | 8.5% | 3.7 | 0.7% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 8 571 690 | -22.9% | 5.2% | -1.2 | 1 717 188 600 | -9.5% | 5.0% | -0.8 | -4.5% |
| DEXALGIN | 1 456 557 | -3.7% | 0.7% | 0 | 623 298 532 | 8.4% | 1.8% | 0 | -0.8% |
| ESPUMISAN (ADULTS) | 3 894 911 | -14.1% | 54.7% | -11.8 | 1 985 622 814 | -3.9% | 60.2% | -10.4 | 4.5% |
| ESPUMISAN BABY | 1 260 762 | -13.3% | 37.6% | -4.1 | 789 779 613 | -6.9% | 50.8% | -5.7 | -3.9% |
| FASTUM | 928 955 | -23.8% | 1.1% | -0.3 | 482 808 123 | -13.9% | 2.5% | -0.6 | -0.3% |
| IODOMARIN | 2 821 112 | 5.2% | 20.3% | 0 | 553 082 687 | 9.9% | 9.1% | -0.1 | 5.1% |
| LIOTON | 1 138 741 | -24.7% | 2.3% | -0.5 | 1 174 068 091 | -5.6% | 4.6% | -1 | -7.4% |
| MEZYM | 15 713 445 | -10.6% | 26.4% | -2.4 | 2 401 512 979 | -2.2% | 18.9% | -2.6 | -2.6% |
| MIG 400 | 7 414 619 | -14.3% | 3.3% | -0.5 | 874 457 719 | -10.3% | 2.5% | -0.6 | -0.8% |
| PROSTAMOL | 1 380 565 | -26.3% | 18.9% | -6.1 | 1 933 169 181 | -17.8% | 20.1% | -7.1 | -2.4% |
| RESPERO MYRTOL | 1 069 028 | 93.9% | 8.6% | 4.2 | 503 238 026 | 94.8% | 8.6% | 3.7 | 0.4% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 10 725 582 | -11.0% | 5.3% | -0.4 | 2 111 038 054 | 2.7% | 5.1% | -0.1 | -5.0% |
| DEXALGIN | 1 782 204 | 0.7% | 0.7% | 0 | 749 385 536 | 11.9% | 1.9% | 0.1 | -2.4% |
| ESPUMISAN (ADULTS) | 4 642 600 | -11.4% | 55.8% | -10.3 | 2 343 224 365 | -0.9% | 61.4% | -8.9 | 4.9% |
| ESPUMISAN BABY | 1 469 108 | -15.0% | 37.8% | -4 | 913 253 789 | -8.3% | 51.2% | -5.1 | -6.1% |
| FASTUM | 1 094 292 | -23.9% | 1.1% | -0.3 | 562 107 889 | -14.4% | 2.6% | -0.6 | -1.7% |
| IODOMARIN | 3 305 225 | 13.1% | 20.6% | 1.6 | 642 213 144 | 16.0% | 9.3% | 0.5 | 4.6% |
| LIOTON | 1 318 790 | -23.1% | 2.3% | -0.5 | 1 333 021 725 | -4.7% | 4.7% | -0.8 | -8.1% |
| MEZYM | 18 900 840 | -7.7% | 27.1% | -1.5 | 2 855 464 945 | -0.0% | 19.5% | -1.9 | -2.6% |
| MIG 400 | 8 651 871 | -12.7% | 3.3% | -0.4 | 1 016 648 412 | -8.9% | 2.6% | -0.5 | -2.4% |
| PROSTAMOL | 1 647 403 | -24.1% | 19.3% | -5.2 | 2 282 385 923 | -15.9% | 20.6% | -6 | -3.8% |
| RESPERO MYRTOL | 1 264 640 | 98.1% | 8.6% | 4.2 | 589 772 588 | 96.5% | 8.5% | 3.7 | 0.7% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 123 524 | -3.6% | 3.2% | -0.3 | 28 293 190 | -1.3% | 3.3% | -0.3 | 4.4% |
| DEXALGIN | 15 879 | 5.6% | 0.4% | 0 | 7 950 277 | 7.8% | 1.2% | 0 | 3.0% |
| ESPUMISAN (ADULTS) | 56 930 | 13.0% | 40.6% | -1.8 | 30 696 566 | 14.9% | 47.3% | -2 | 18.1% |
| ESPUMISAN BABY | 23 604 | 10.7% | 34.1% | 2.1 | 15 821 626 | 14.4% | 47.4% | 2.1 | 3.7% |
| FASTUM | 16 940 | 12.9% | 1.0% | 0 | 9 627 629 | 13.6% | 2.4% | 0.1 | 7.6% |
| IODOMARIN | 70 622 | 6.2% | 23.2% | -0.2 | 13 159 934 | 6.5% | 9.8% | -0.2 | 7.2% |
| LIOTON | 17 092 | 25.5% | 1.8% | 0.3 | 19 297 838 | 27.3% | 4.3% | 0.8 | 2.0% |
| MEZYM | 210 162 | 8.0% | 18.5% | 0.4 | 31 237 965 | 8.0% | 13.0% | 0.3 | 5.8% |
| MIG 400 | 130 056 | 4.8% | 2.9% | 0 | 15 717 210 | 4.7% | 2.3% | 0 | 3.0% |
| PROSTAMOL | 23 828 | 15.4% | 14.1% | 0 | 33 164 846 | 17.8% | 15.2% | 0.4 | 15.1% |
| RESPERO MYRTOL | 21 709 | 12.5% | 7.0% | 0.4 | 10 965 619 | 16.5% | 7.6% | 0.6 | 6.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 663 634 | -11.2% | 3.7% | 0 | 141 897 078 | -7.6% | 3.9% | 0.1 | -11.7% |
| DEXALGIN | 86 956 | -4.2% | 0.4% | 0 | 43 128 669 | -0.4% | 1.4% | 0.2 | -15.1% |
| ESPUMISAN (ADULTS) | 239 485 | -14.9% | 42.7% | -3.6 | 125 979 753 | -15.3% | 49.0% | -3 | -7.8% |
| ESPUMISAN BABY | 100 666 | -10.7% | 32.4% | -2.5 | 65 668 391 | -11.0% | 45.8% | -2.4 | -3.7% |
| FASTUM | 64 329 | -16.9% | 0.8% | -0.1 | 36 346 604 | -13.8% | 2.1% | -0.1 | -7.5% |
| IODOMARIN | 358 258 | 6.7% | 24.2% | -0.2 | 66 228 362 | 6.5% | 10.6% | -0.2 | 7.5% |
| LIOTON | 68 286 | -18.3% | 1.6% | -0.2 | 75 928 498 | -15.9% | 3.8% | -0.1 | -7.2% |
| MEZYM | 920 938 | -9.0% | 18.8% | -0.1 | 140 372 345 | -9.1% | 13.5% | 0.2 | -8.4% |
| MIG 400 | 590 420 | -16.3% | 2.8% | 0 | 71 281 785 | -15.1% | 2.2% | 0 | -15.1% |
| PROSTAMOL | 104 788 | -2.2% | 15.4% | 0.3 | 144 315 206 | -3.2% | 16.3% | 0.2 | -4.2% |
| RESPERO MYRTOL | 99 923 | -10.4% | 7.6% | -0.1 | 48 921 001 | -8.4% | 7.9% | -0.1 | -9.0% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"
## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"
## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"
## [1] "ESPUMISAN (ADULTS)"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"
## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"
## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"
## [1] "ESPUMISAN BABY"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"
## [1] "FASTUM"
## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"
## [1] "LIOTON"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"
## [1] "MEZYM"
## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS #20"
## [1] "MEZYM FORTE COATED TABLETS #20"
## [1] "MEZYM FORTE COATED TABLETS #80"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"
## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS #20"
## [1] "DEXALGIN"
## [1] "DEXALGIN 25 COATED TABLETS 25 MG #10"
## [1] "MIG 400"
## [1] "MIG 400 COATED TABLETS 400 MG #10"
## [1] "MIG 400 COATED TABLETS 400 MG #20"
## [1] "PROSTAMOL"
## [1] "PROSTAMOL UNO CAPS 320 MG #30"
## [1] "PROSTAMOL UNO CAPS 320 MG #60"
## [1] "PROSTAMOL UNO CAPS 320 MG #90"
## [1] "IODOMARIN"
## [1] "IODOMARIN 100 TABS 100 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #50"
## [1] "IODOMARIN FOR THE FUTURE MOTHER TABLETS 140 MG #30"
## [1] "RESPERO MYRTOL"
## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"
## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs